Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cerebral endothelial cell adhesion molecule (CERCAM) is a probable cell adhesion protein expressed at the brain endothelium, where it is involved in mediating leukocyte transmigration across the blood-brain barrier. It is predicted to be located at the plasma membrane and is involved in cell-cell adhesion processes. Unlike many glycosyltransferases, CERCAM does not display enzymatic activity in vitro. Its expression and function are thought to contribute to immune cell entry into the CNS under physiological and pathological conditions. In cancer, upregulation or altered expression of CERCAM and other cell adhesion molecules in the brain may facilitate tumor cell adhesion, migration, and eventual brain metastasis, making it a potential, though not yet validated, therapeutic target in neuro-oncology and neuroimmunology[6][7][8][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cerebral endothelial cell adhesion molecule (CERCAM).